Cultivated meat involves growing meat and other components (like fat) directly from animal cells. Cultivated meat can be used to produce standalone products, or as an ingredient in plant-based products to improve their taste and texture.
New Systemiq analysis, supported by the Good Food Institute Europe, estimates that current policies put the UK on track for a cultivated meat end-product market worth around £1.1 billion a year by 2050.
However, the same modelling shows that more ambitious, coordinated support could lift the UK’s addressable cultivated meat market to around £3 billion annually by 2050, with domestic production and exports together creating close to £5 billion of economic value across the value chain.
Under this high-ambition pathway, the analysis suggests the UK could see roughly three times the gross value added (GVA) and export gains compared with a business-as-usual trajectory, reflecting larger domestic scale-up and stronger export competitiveness.
These scenarios reflect different patterns of demand, innovation, and government support. The modelling combines global alternative-protein adoption trends with UK-specific assumptions about market development, self-sufficiency, and export share, using proxy sectors to estimate how quickly domestic supply and exports could grow.
The UK already has internationally recognised research groups and firms in cultivated meat, and recently became the first European country to allow sales of cultivated meat in pet food – a sign of regulatory momentum and technical strength. Yet significant barriers remain, including production cost, scale-up infrastructure, and public acceptance.
To help address these barriers, the Food Standards Agency (FSA) has launched a regulatory sandbox for cell-cultivated products, backed by government funding, aimed at speeding safe approvals and giving companies clarity on evidence requirements.
If successfully scaled, cultivated meat could become a meaningful pillar of the UK’s next-generation food economy – strengthening food system resilience, supporting high-value manufacturing and life sciences, and creating a new export-ready sector aligned with net-zero goals.
